In this Pharmaceutical Executive video interview, Currax Pharmaceuticals, CEO, George Hampton, discusses factors that are contributing to ongoing supply issues and if prices for these therapies are coming down anytime soon.
Supply Shortages in Weight Loss Drugs
You May Also Like
+ There are no comments
Add yours